Arteriovenous fistula as stable venous access in children with severe haemophilia

Haemophilia

Volumn 16, Issue SUPPL. 1, 2010, Pages 25-28

  Mancuso, M E ^a   Berardinelli, L ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Arteriovenous fistula; Haemophilia; Inhibitor; Prophylaxis; Venous access

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ANEURYSM; ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT; CHILD; CHILD CARE; CONTINUOUS INFUSION; DISEASE SEVERITY; FOLLOW UP; HEMATOMA; HEMOPHILIA; HOME CARE; HUMAN; INFECTION; ISCHEMIA; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; THROMBOSIS; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; CHILD; CHILD, PRESCHOOL; FACTOR VIII; HEMOPHILIA A; HUMANS; POSTOPERATIVE COMPLICATIONS;

EID: 73949156853     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02158.x     Document Type: Review

References (18)

1. Berntorp E, Boulyjenkov V, Brettler D. Modern treatment of hemophilia. Bull World Health Organ 1995, 73:691-701.
2. MASAC recommendations concerning prophylaxis (regular administration of clotting factor concentrate to prevent bleeding). 2006, http://www.hemophilia.org/NHFWeb/Resource/StaticPages/menu0/menu5/menu57/170.pdf, Available at: Accessed 2 December 2009
3. Guidelines for the management of hemophilia. 2005, http://www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/Guidelines_Mng_Hemophilia.pdf, Available at: Accessed 2 December 2009
4. Manco-Johnson MJ, Abshire TC, Shapiro AD. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007, 357:535-44.
5. DiMichele DM, Hoots K, Pipe SW, Rivard GE, Santagostino E. International workshop on immune tolerance induction: consensus recommendations. Hemophilia 2007, 13(Suppl. 1):1-22.
6. Valentino LA, Ewenstein B, Navickis RJ, Wilkes MM. Central venous access devices in hemophilia. Hemophilia 2004, 10:134-46.
7. Brescia MJ, Cimino JF, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966, 275:1089-92.
8. Kherlakian GM, Roedersheimer LR, Arbaugh JJ, Newmark KJ, King LR. Comparison of autogenous fistula versus expended polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg 1986, 152:238-43.
9. Bonalumi U, Civalleri D, Rovida S, Adami GF, Gianetta E, Griffanti-Bartoli F. Nine years' experience with end-to-end arteriovenous fistula at the anatomical snuffbox for maintenance hemodialysis. Br J Surg 1982, 69:486-8.
10. Lumsden AB, MacDonald J, Allen RC, Dodson TF. Hemodialysis access in the pediatric patient population. Am J Surg 1994, 168:197-201.
11. Santagostino E, Gringeri A, Berardinelli L, Beretta C, Muça-Perja M, Mannucci PM. Long-term safety and feasibility of artriovenous fistulae as vascular accesses in children with hemophilia: a prospective study. Br J Haematol 2003, 123:502-6.
12. McCarthy WJ, Valentino LA, Bonilla AS. Arteriovenous fistula for long-term venous access for boys with hemophilia. J Vasc Surg 2007, 45:986-91.
13. Mancuso ME, Berardinelli L, Beretta C, Raiteri M, Pozzoli E, Santagostino E. Improved treatment feasibility in children with hemophilia using arteriovenous fistula: the results after seven years of follow-up. Haematologica 2009, 94:687-92.
14. Feldman HI, Goldberg EM, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996, 7:523-35.
15. Erkut B, Ünlü Y, Ceviz M. Primary arteriovenous fistulas in the forearm for hemodialysis: effect of miscellaneous factors in fistula patency. Ren Fail 2006, 28:275-81.
16. Huber TS, Ozaki CK, Flynn TC. Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. J Vasc Surg 2002, 36:452-9.
17. Mancuso ME, Mannucci PM, Sartori A, Agliardi A, Santagostino E. Feasibility of prophylaxis and immune tolerance induction regimens in hemophilic children using fully implantable central venous catheters. Br J Haematol 2008, 141:689-95.
18. DiMichele DM, Hay CR. The international immune tolerance study: a multicenter prospective randomized trial in progress. J Thromb Hemost 2006, 4:2271-3.